Legis Daily

To establish programs related to prevention of prescription opioid misuse, and for other purposes.

USA115th CongressHR-5865| House 
| Updated: 7/24/2018
Matt Cartwright

Matt Cartwright

Democratic Representative

Pennsylvania

Committees (6)
• Ways and Means Committee• Crime and Federal Government Surveillance Subcommittee• Health Subcommittee• Judiciary Committee• Energy and Commerce Committee• Education and Workforce Committee
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Addiction Prevention and Responsible Opioid Practices Act This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 23, 2018

Latest Companion Bill Action

S 115-2729
Introduced in Senate
May 17, 2018
Introduced in House
May 17, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 4, 2018
Referred to the Subcommittee on Health.
Jul 24, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • April 23, 2018

    Latest Companion Bill Action

    S 115-2729
    Introduced in Senate


  • May 17, 2018
    Introduced in House


  • May 17, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • June 4, 2018
    Referred to the Subcommittee on Health.


  • July 24, 2018
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Health

Related Bills

  • S 115-2729: A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.
Alternative treatmentsBusiness ethicsBusiness recordsCongressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care qualityHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careIndian social and development programsLicensing and registrationsMarketing and advertisingMedical educationMedical ethicsMedicareMilitary medicineMinority healthPrescription drugsSales and excise taxesState and local government operationsUser charges and feesVeterans' medical care

To establish programs related to prevention of prescription opioid misuse, and for other purposes.

USA115th CongressHR-5865| House 
| Updated: 7/24/2018
Addiction Prevention and Responsible Opioid Practices Act This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 23, 2018

Latest Companion Bill Action

S 115-2729
Introduced in Senate
May 17, 2018
Introduced in House
May 17, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 4, 2018
Referred to the Subcommittee on Health.
Jul 24, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • April 23, 2018

    Latest Companion Bill Action

    S 115-2729
    Introduced in Senate


  • May 17, 2018
    Introduced in House


  • May 17, 2018
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • June 4, 2018
    Referred to the Subcommittee on Health.


  • July 24, 2018
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Matt Cartwright

Matt Cartwright

Democratic Representative

Pennsylvania

Committees (6)
• Ways and Means Committee• Crime and Federal Government Surveillance Subcommittee• Health Subcommittee• Judiciary Committee• Energy and Commerce Committee• Education and Workforce Committee

Health

Related Bills

  • S 115-2729: A bill to establish programs related to prevention of prescription opioid misuse, and for other purposes.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Alternative treatmentsBusiness ethicsBusiness recordsCongressional oversightDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care qualityHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHospital careIndian social and development programsLicensing and registrationsMarketing and advertisingMedical educationMedical ethicsMedicareMilitary medicineMinority healthPrescription drugsSales and excise taxesState and local government operationsUser charges and feesVeterans' medical care